和黄医药:2026年上半年净收益1590万美元

智通财经
Jul 30
【和黄医药:2026年上半年净收益1590万美元】和黄医药公告,2026年上半年综合收入2.78亿美元,与2025年上半年2.78亿美元基本持平。净收益为1590万美元,上年同期为4.55亿美元。肿瘤/免疫业务综合收入1.62亿美元,同比增长13%。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10